Impact of Nuun SPORT on Subjective Exercise Performance in Male and Female Runners

August 19, 2022 updated by: Richard Bloomer, University of Memphis
The study will examine the impact of the Nuun Sport tablets, as compared to water only, on heart rate, perceived exertion, and related outcomes in male and female runners, during and following the performance of a 60-minute treadmill run.

Study Overview

Status

Completed

Conditions

Detailed Description

As discussed in our prior applications (protocol FY2020-327 and FY2021-96), maintaining adequate hydration is essential to optimal health (Perrier, 2017), as well as athletic performance (Nuccio et al., 2017). When individuals exercise (in particular in a warm environment), they can lose excessive amounts of fluids through sweating, along with necessary electrolytes (e.g., sodium, potassium, chloride). With dehydration, individuals may feel sluggish and can experience impaired physical performance. (Kenefick, 2018)

Many attempts have been made to improve and measure the hydration status of active individuals (Love et al., 2018). This typically involves the ingestion of fluids leading up to activity (typically plain water), as well as the ingestion of fluids during the activity itself (water, along with a diluted carbohydrate/electrolyte beverage).

During aerobic exercise, the shift in fluid (intake versus losses) can affect electrolyte balance, with dehydration and potential adverse effects on performance and health (Perrier et al., 2021; Armstrong et al. 2021). A better understanding of rehydration methods and resultant efficacy would permit selection by an athlete of the optimal method for preventing dehydration to optimize physical performance and reduce potential deleterious effects.

It is well-accepted that electrolyte replenishment is of importance, both during and following exercise-to aid in rehydration for subsequent bouts. Electrolytes (sodium in particular) have been used for decades to aid athlete hydration and this has led to the development of various sport drinks-which also include small amounts of carbohydrate (e.g., Gatorade, Powerade).

The present study will examine the impact of the Nuun Sport tablets, as compared to water only, on heart rate, perceived exertion, and related outcomes: changes in body mass, changes in plasma volume, post-exercise urine volume, and changes in urine specific gravity in male and female runners, during and/or following the performance of a 60-minute treadmill run.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Tennessee
      • Memphis, Tennessee, United States, 38152
        • Center for Nutraceutical and Dietary Supplement Research

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • body mass index (BMI) between 18-29.9 kg/m2 (not obese)
  • be able to fast overnight (>8 hrs)
  • consuming a minimum of two liters of water per day, on a regular basis
  • distance runners: run ≥ 15 miles/week, ≥ 3 runs/week, for at least the past 6 months
  • have completed a run of 60 minutes or more at least once per month for the past 6 months
  • normal resting blood pressure (systolic < 140 mmHg, diastolic < 90 mmHg) and heart rate (40-80bpm)
  • a negative verbal pre-study drug screen (alcohol abuse, amphetamines, benzodiazepines, cocaine, opioids, phencyclidine, barbiturates, cotinine) and no history of use of illicit drugs or other substances of abuse within 12 months of the screening visit

Exclusion Criteria:

  • tobacco user
  • if female, pregnant
  • history of known cardiovascular disease
  • more than 400mg caffeine intake per day
  • self-reported active infection or illness of any kind
  • consumption of alcohol-containing beverages within 48 hours of testing
  • consumption of caffeine-containing beverages within 48 hours of testing
  • strenuous exercise within 48 hours of testing

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Nuun Sport
Citric Acid, Dextrose, Sodium Carbonate, Potassium Bicarbonate, Sodium Bicarbonate, Natural Flavors, Potassium Chloride, Magnesium Oxide, Calcium Carbonate, Stevia Leaf Extract, Avocado Oil, Riboflavin (for color).
Subjects will consume a total of 24 ounces water and 1.5 tablets of Nuun SPORT. Specifically, subjects will drink 12 ounces of Nuun drink 15 minutes prior to the 60 min run and 4 ounces of Nuun drink at 15 min, 30 min, and 45 min during the run.
Sham Comparator: Control
Water
Subjects will consume a total of 24 ounces water. Specifically, subjects will drink 12 ounces of water 15 minutes prior to the 60 min run and 4 ounces of water at 15 min, 30 min, and 45 min during the run.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart rate
Time Frame: baseline
Heart rate will be measured before and every 10 minutes during the run using a chest strap
baseline
Heart rate
Time Frame: 10 minutes into run
Heart rate will be measured before and every 10 minutes during the run using a chest strap
10 minutes into run
Heart rate
Time Frame: 20 minutes into run
Heart rate will be measured before and every 10 minutes during the run using a chest strap
20 minutes into run
Heart rate
Time Frame: 30 minutes into run
Heart rate will be measured before and every 10 minutes during the run using a chest strap
30 minutes into run
Heart rate
Time Frame: 40 minutes into run
Heart rate will be measured before and every 10 minutes during the run using a chest strap
40 minutes into run
Heart rate
Time Frame: 50 minutes into run
Heart rate will be measured before and every 10 minutes during the run using a chest strap
50 minutes into run
Heart rate
Time Frame: 60 minutes into run
Heart rate will be measured before and every 10 minutes during the run using a chest strap
60 minutes into run
Perceived exertion
Time Frame: baseline
Subjects will self-report perceived exertion using a scale from 0 (no exertion) to 10 (the most exertion)
baseline
Perceived exertion
Time Frame: 10 minutes into run
Subjects will self-report perceived exertion using a scale from 0 (no exertion) to 10 (the most exertion)
10 minutes into run
Perceived exertion
Time Frame: 20 minutes into run
Subjects will self-report perceived exertion using a scale from 0 (no exertion) to 10 (the most exertion)
20 minutes into run
Perceived exertion
Time Frame: 30 minutes into run
Subjects will self-report perceived exertion using a scale from 0 (no exertion) to 10 (the most exertion)
30 minutes into run
Perceived exertion
Time Frame: 40 minutes into run
Subjects will self-report perceived exertion using a scale from 0 (no exertion) to 10 (the most exertion)
40 minutes into run
Perceived exertion
Time Frame: 50 minutes into run
Subjects will self-report perceived exertion using a scale from 0 (no exertion) to 10 (the most exertion)
50 minutes into run
Perceived exertion
Time Frame: 60 minutes into run
Subjects will self-report perceived exertion using a scale from 0 (no exertion) to 10 (the most exertion)
60 minutes into run
Specific gravity of urine
Time Frame: baseline
Specific gravity will be determined from a urine sample
baseline
Specific gravity of urine
Time Frame: 15 minutes after run
Specific gravity will be determined from a urine sample
15 minutes after run
Plasma Volume
Time Frame: baseline
Plasma Volume will be determine via blood sampling and determination of hematocrit and hemoglobin
baseline
Plasma Volume
Time Frame: 5 minutes after run
Plasma Volume will be determine via blood sampling and determination of hematocrit and hemoglobin
5 minutes after run
Body Mass
Time Frame: baseline
Body Mass will be measured
baseline
Body Mass
Time Frame: 5 minutes after run
Body Mass will be measured
5 minutes after run
Body Mass
Time Frame: 15 minutes post-run after urine collection
Body Mass will be measured
15 minutes post-run after urine collection
Urine output (mass)
Time Frame: 15 minutes post-run
Urine mass will be determine following collection
15 minutes post-run
Urine output (volume)
Time Frame: 15 minutes post-run
Urine volume will be determine following collection
15 minutes post-run

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 19, 2022

Primary Completion (Actual)

May 10, 2022

Study Completion (Actual)

May 10, 2022

Study Registration Dates

First Submitted

December 8, 2021

First Submitted That Met QC Criteria

August 19, 2022

First Posted (Actual)

August 22, 2022

Study Record Updates

Last Update Posted (Actual)

August 22, 2022

Last Update Submitted That Met QC Criteria

August 19, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • PRO-FY2021-417

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe